Aridis Pharmaceuticals Competitors and Similar CompaniesClear all
Aridis Pharmaceuticals's competitors and similar companies include Taiwan Liposome, Gero, Sanofi Genzyme and Innovent Biologics.
 Aridis Pharmaceuticals Aridis Pharmaceuticals is focused on the development of novel, differentiated therapies for infectious diseases. |  Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). |  Gero Gero is a biotechnology company intended to evaluate the personal risks of mortality and health. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  Innovent Biologics Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies. | |
Founding Date | Founding Date 2003 | Founding Date 1997 | Founding Date 2015 | Founding Date 1981 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations San Jose, US HQ Los Gatos, US | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Singapore, SG HQ Agios Athanasios, CY Moskva, RU | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Fangshan Qu, CN HQ |
Employees | Employees 238% decrease | Employees 1652% decrease | Employees 105 | Employees 9,9041% decrease | Employees 831 |
Financial | |||||
Revenue (est.) | Revenue (est.) $3.1m (FY, 2022) | Revenue (est.) NT$101.9m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) N/A |
Net income | Net income ($30.4m) (FY, 2022) | Net income (NT$983.3m) (FY, 2020) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2.2m (almost 6 years ago) | Latest funding round N/A | Latest funding round $ 150m (about 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised N/A | Total funding raised $ 560m |
For sources of this data, please see the company profile
View Company Profiles
Taiwan Liposome
HQ
Taipei, TW
Employees
165↓ 2% decrease
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View companyGero
HQ
Singapore, SG
Employees
105
Gero is a biotechnology company intended to evaluate the personal risks of mortality and health.
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View companyInnovent Biologics
HQ
Fangshan Qu, CN
Employees
831
Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.
View company